<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: Medical Laboratories &amp; Research Industry News</title><link>http://biz.yahoo.com/ic/news/525.html</link><description>The latest news on the Medical Laboratories &amp; Research industry from Yahoo! Finance</description><language>en-us</language><lastBuildDate>Fri, 18 Dec 2009 15:30:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>End of H1N1 &apos;Second Wave&apos; in Sight in the U.S., According to Quest Diagnostics (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091218/ny28401.html?.v=1</link><description>Rates of 2009 H1N1 influenza virus testing in the U.S. have declined more than 75 percent since their peak in late October, suggesting that the &quot;second wave&quot; of virus infection that sickened tens of millions of Americans since it began four months ago may be coming to an end, according to a new report by Quest Diagnostics Incorporated , the world&apos;s leading provider of diagnostic testing, information and services.</description><guid isPermaLink="false">yahoo_finance/2306888894</guid><pubDate>Fri, 18 Dec 2009 15:30:00 Etc/GMT</pubDate></item><item><title>Pacific Biometrics, Inc. Stockholders Approve Company Name Change to Pacific Biomarkers, Inc. (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091218/la28252.html?.v=1</link><description>Pacific Biometrics, Inc. , a leading provider of specialized central laboratory and contract research services, today announced that its stockholders approved all three proposals that were voted upon at the Company&apos;s Annual Meeting on December 14, 2009.</description><guid isPermaLink="false">yahoo_finance/2220121734</guid><pubDate>Fri, 18 Dec 2009 13:30:00 Etc/GMT</pubDate></item><item><title>Alliance expects 2010 revenue decline (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_alliance_healthcare_services_outlook.html?.v=1</link><description>Alliance HealthCare Services Inc. which provides diagnostic imaging and cancer-treating radiation services, on Thursday reaffirmed it 2009 revenue outlook but expects a dip in 2010.</description><guid isPermaLink="false">yahoo_finance/3136898754</guid><pubDate>Thu, 17 Dec 2009 21:56:45 Etc/GMT</pubDate></item><item><title>PPD Selected as Exclusive Partner by DiabetesAmerica (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091217/20091217006286.html?.v=1</link><description>WILMINGTON, N.C.----PPD, Inc. today announced it has entered into an exclusive alliance with DiabetesAmerica™, a provider of comprehensive diabetes care services based in Houston, Texas.</description><guid isPermaLink="false">yahoo_finance/3310362147</guid><pubDate>Thu, 17 Dec 2009 21:10:00 Etc/GMT</pubDate></item><item><title>Alliance HealthCare Services Reaffirms 2009 Guidance and Announces Full Year 2010 Financial Guidance (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091217/20091217006234.html?.v=1</link><description>NEWPORT BEACH, Calif.----Alliance HealthCare Services, Inc. , a leading national provider of outpatient diagnostic imaging and radiation therapy services, reaffirmed 2009 guidance and announced financial guidance for full year 2010.</description><guid isPermaLink="false">yahoo_finance/1582975204</guid><pubDate>Thu, 17 Dec 2009 21:00:00 Etc/GMT</pubDate></item><item><title>Bio-Reference 4Q profit jumps 37 percent (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_earns_bio_reference_laboratories.html?.v=1</link><description>Bio-Reference Laboratories Inc., which provides clinical laboratory testing services, said Thursday its fiscal 2009 fourth-quarter profit jumped 37 percent on growth in blood testing and other units.</description><guid isPermaLink="false">yahoo_finance/3154223524</guid><pubDate>Thu, 17 Dec 2009 19:45:32 Etc/GMT</pubDate></item><item><title>Second Study Supports that NGAL Test Identifies Acute Kidney Injury Early in Critically Ill Patients (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091217/ne27786.html?.v=1</link><description>According to a new study published last week in Intensive Care Medicine, a novel bedside blood test measured in critically ill patients being admitted to the intensive care unit can help to identify which patients are at risk for acute kidney injury .</description><guid isPermaLink="false">yahoo_finance/2629638840</guid><pubDate>Thu, 17 Dec 2009 14:00:00 Etc/GMT</pubDate></item><item><title>Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and Fiscal Year (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091217/20091217005332.html?.v=1</link><description>ELMWOOD PARK, N.J.----Bio-Reference Laboratories, Inc. announced best ever Company quarterly and annual fiscal year results, topping one hundred million in net revenue during the quarter for the first time.</description><guid isPermaLink="false">yahoo_finance/3831017454</guid><pubDate>Thu, 17 Dec 2009 13:30:00 Etc/GMT</pubDate></item><item><title>National Dentex Corporation Announces Management Succession Plan (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091216/20091216005946.html?.v=1</link><description>NATICK, Mass.----National Dentex Corporation , one of the largest owner/operators of dental laboratories in North America, today announced that its Board of Directors has approved a succession and transition plan that will ensure continued leadership at the Company.</description><guid isPermaLink="false">yahoo_finance/444786275</guid><pubDate>Wed, 16 Dec 2009 19:00:00 Etc/GMT</pubDate></item><item><title>Stem Cell Therapy Featured in The Rose Sheet (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091216/0569696.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1845938782</guid><pubDate>Wed, 16 Dec 2009 15:00:00 Etc/GMT</pubDate></item><item><title>Cord Blood America Says 2009 Debt Reduction Tops $10 Million (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091216/la26946.html?.v=1</link><description>Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has reduced its debt by a total of $1.4 million so far in the fourth quarter of 2009 and total debt eliminated for the year now tops $10 million.</description><guid isPermaLink="false">yahoo_finance/3660385358</guid><pubDate>Wed, 16 Dec 2009 14:00:00 Etc/GMT</pubDate></item><item><title>InvestorSoup Initiates Independent Research Coverage for Array BioPharma Inc. (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091216/180414.html?.v=1</link><description>DALLAS -- InvestorSoup.com announces an investment report featuring Array BioPharma Inc. . The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.</description><guid isPermaLink="false">yahoo_finance/1944680507</guid><pubDate>Wed, 16 Dec 2009 11:50:00 Etc/GMT</pubDate></item><item><title>Genoptix, Inc. (GXDX): Zacks Rank Buy (Zacks.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091216/zacks13041000000commentary.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1689853615</guid><pubDate>Wed, 16 Dec 2009 06:00:00 Etc/GMT</pubDate></item><item><title>Its Diagnostic Tests Help Doctors And Patients Work Faster (Investor&apos;s Business Daily)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ibd/091215/newamer.html?.v=1</link><description>Inverness Medical Innovations is a company built on speed.</description><guid isPermaLink="false">yahoo_finance/216128012</guid><pubDate>Tue, 15 Dec 2009 23:16:53 Etc/GMT</pubDate></item><item><title>Array BioPharma shares rise on Amgen deal (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091215/us_array_biopharma_mover.html?.v=1</link><description>Shares of Array BioPharma Inc. surged Tuesday after the company struck a development deal with Amgen Inc. worth $60 million upfront for a potential type 2 diabetes treatment.</description><guid isPermaLink="false">yahoo_finance/1382617575</guid><pubDate>Tue, 15 Dec 2009 18:56:24 Etc/GMT</pubDate></item><item><title>Emerging Stock Report Initiates Independent Research Coverage on Array BioPharma Inc. (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180342.html?.v=1</link><description>CALGARY, Alberta -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Array BioPharma Inc., . Emerging Stock Report is currently offering a complimentary trial subscription to the investment community.</description><guid isPermaLink="false">yahoo_finance/1473659120</guid><pubDate>Tue, 15 Dec 2009 16:04:44 Etc/GMT</pubDate></item><item><title>Covance Opens New Clinical Development Offices in South Korea and India; Expands Offices in Japan and Hong Kong (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091215/ph25931.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3932271325</guid><pubDate>Tue, 15 Dec 2009 14:00:00 Etc/GMT</pubDate></item><item><title>Amgen, Array BioPharma enter development agreement (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091215/us_amgen_array_biopharma_agreement.html?.v=1</link><description>Biotech drug developer Amgen Inc. has entered an agreement with Array BioPharma Inc. to develop a potential treatment for type 2 diabetes, the companies said late Monday.</description><guid isPermaLink="false">yahoo_finance/3676453153</guid><pubDate>Tue, 15 Dec 2009 13:51:47 Etc/GMT</pubDate></item><item><title>LabCorp Receives Notification from the Holders of the Minority Interest in the Company&apos;s Ontario, Canada Joint Venture (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091215/20091215005117.html?.v=1</link><description>BURLINGTON, N.C.----Laboratory Corporation of America® Holdings announced today that it has received notification from the holders of the minority interest in the Company&apos;s Ontario, Canada joint venture, that they intend to put their remaining partnership units to the Company in accordance with the terms of the joint venture’s partnership agreement.</description><guid isPermaLink="false">yahoo_finance/3639874379</guid><pubDate>Tue, 15 Dec 2009 13:30:00 Etc/GMT</pubDate></item><item><title>Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091215/sf26067.html?.v=1</link><description>Genomic Health, Inc. today announced results from five new studies on its Oncotype DX® breast cancer test, a multi-gene expression test that physicians currently use to predict the likelihood of chemotherapy benefit and recurrence risk for patients with early-stage breast cancer.</description><guid isPermaLink="false">yahoo_finance/2395787405</guid><pubDate>Tue, 15 Dec 2009 13:00:00 Etc/GMT</pubDate></item></channel></rss><!-- c3.finance.sp2.yahoo.com compressed/chunked Fri Dec 18 19:04:44 PST 2009 -->
